|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 498/14 | |
| A61K 47/48 | |||
| G01N 33/50 | |||
| A61K 31/5383 |
| (11) | Number of the document | 2240495 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09707128.6 |
| Date of filing the European patent application | 2009-01-16 | |
| (97) | Date of publication of the European application | 2010-10-20 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/031199 |
| Date | 2009-01-16 |
| (87) | Number | WO 2009/099741 |
| Date | 2009-08-13 |
| (30) | Number | Date | Country code |
| 25504 | 2008-02-01 | US |
| (72) |
COHEN, Robert L., US
HA, Edward Hyungsuk, US
REYNOLDS, Mark E., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS |
| NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS |